United BioSource Corporation Acquires Total Healthcare Group
United BioSource Corporation
(UBC), a wholly owned subsidiary of Medco Health Solutions, Inc., today announced the acquisition of Total Healthcare Group (THG), a London-based international consultancy serving clients in the biopharmaceutical industry. THG provides global payer research, strategic planning, and global value dossiers for biopharmaceutical products.
THG, together with UBC’s existing value strategy and research services, will be led by THG’s Dr. Robert Hollamby, who has been appointed Senior Vice President at UBC.
“Demonstrating value and providing evidence-based research that allows stakeholders in the health care market to make important economic decisions surrounding biopharmaceuticals and devices is crucial in the market place,” said UBC President Mark Clein. “UBC helps clients respond effectively to the evolving health care environment by researching, communicating, and demonstrating value in medicines. The addition of THG significantly expands our capabilities and geographic reach and allows us to launch a comprehensive practice that we expect to be a leader in the global biopharmaceutical industry.”
Results International served as THG’s financial advisor in this transaction.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
